Survey: People with NMOSD Remain Hopeful Despite Various Obstacles

Nearly six in 10 NMOSD In America survey respondents said being part of an online community of people living with NMOSD has helped them feel less alone.

Survey: Diagnosis, Treatment Obstacles for People with Chronic Hives

Three in 10 Chronic Hives In America survey respondents said they considered their chronic hives to be controlled on their current treatment plan.

Health Union Opens Nominations for Inaugural Social Health Awards

Social Health Awards nominations are open to patient leaders who are active, leading members of an online community and making a difference in healthcare.

Health Union Launches First-of-its-Kind Social Health Network

The Social Health Network represents an evolution of Health Union’s mission to help people with chronic and complex conditions live better.

HU President Lauren Lawhon Recognized Among 2022 PM360 ELITE

Lawhon has been instrumental in identifying how to manage priorities as Health Union navigates new opportunities, changing dynamics and impressive growth.

Health Union Recognized Among Fastest-Growing Companies by Financial Times

Health Union made the list with a 247.2% annual growth rate in revenue between 2017 and 2020 and a 51.4% compound annual growth rate.

Survey: Focal Seizures Lead to Complex Epilepsy Treatment Journey

Respondents with focal seizures were more likely than those who aren’t to currently be using prescription medications and various alternative therapies.

Survey: Treatment Plan Discussions Differ from Adherence Challenges

With the highest percentage, 27% of respondents said they viewed cost as a challenge to staying on their medication as prescribed or instructed.

Health Union Ranks No. 449 in 2021 Deloitte Technology Fast 500

Health Union ranked No. 449 on Deloitte’s 2021 Technology Fast 500™, continuing to experience exponential growth since the company started in 2010.

Quality of Life Impact Research Presented at Three Fall Conferences

The findings focus on the patient-reported impact of cystic fibrosis, hidradenitis suppurativa and spondyloarthritis on various quality of life factors.